UBC Mood Disorders Centre
Welcome,         Profile    Billing    Logout  
 17 Trials 
31 Trials

   

Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Yatham, Lakshmi
SMART-BD, NCT06433635: Sequential Multiple Assignment Randomized Trial for Bipolar Depression

Not yet recruiting
4
2726
Canada, US
Cariprazine, Vraylar, Aripiprazole/Escitalopram combination, Abilify/ Lexapro, Quetiapine, Seroquel, Lurasidone, Latuda
Massachusetts General Hospital, Patient-Centered Outcomes Research Institute
Bipolar I Disorder, Depression
02/30
02/30
ELICE_BD, NCT02731612: Study of the Efficacy of Lurasidone in Cognitive Functioning in Bipolar Patients

Recruiting
3
150
Europe, Canada, Japan, US
lurasidone, Latuda, Placebo
Nazlin Walji
Bipolar Disorder
12/24
03/25
CARPZ-01, NCT04771299: Assessing the Role of Cariprazine in Improving Cognition in Euthymic Bipolar Patients

Terminated
3
1
Canada
Cariprazine, VRAYLAR®, Placebo
Lakshmi N Yatham
Bipolar I Disorder, Cognitive Impairment
09/24
09/24
CBD-BD, NCT05867849: Cannabidiol for Bipolar Depression

Recruiting
3
360
Canada
Cannabidiol, CBD, Placebo
University of British Columbia
Bipolar Disorder
12/29
12/30
Tam, Edwin
NCT04944758: Feasibility of Adherence to Light Therapy

Terminated
N/A
1
Canada
Light therapy
University of British Columbia, Michael Smith Foundation for Health Research
Major Depression in Remission
06/22
06/22
Lam, Raymond W
CAN-BIND-17, NCT05017311: Optimized Predictive Treatment In Medications for Unipolar Major Depression (OPTIMUM-D)

Recruiting
4
400
Canada
Escitalopram, Cipralex, Brexpiprazole, Rexulti
Nova Scotia Health Authority, Unity Health Toronto, Centre for Addiction and Mental Health, McMaster University, Queen's University, University of Ottawa, University of British Columbia, University of Calgary, McGill University, Dalhousie University, University of Michigan, Simon Fraser University
Major Depressive Disorder
12/28
04/29
NCT04162522: Canadian Biomarker Integration Network for Depression (CAN-BIND) - Validation Study

Completed
3
1
Canada
Escitalopram, Cipralex, Brexpiprazole, Rexulti
University Health Network, Toronto, Unity Health Toronto, Baycrest, Centre for Addiction and Mental Health, McMaster University, Queen's University, University of Ottawa, University of British Columbia, University of Calgary, McGill University, Dalhousie University, University of Michigan, Simon Fraser University
Major Depressive Disorder
12/22
12/22
NCT04944758: Feasibility of Adherence to Light Therapy

Terminated
N/A
1
Canada
Light therapy
University of British Columbia, Michael Smith Foundation for Health Research
Major Depression in Remission
06/22
06/22
NCT03762460: A Pilot Study of eHealth Tools in a Tertiary-care Setting

Completed
N/A
60
Canada
Online eHealth tool, Informational website
University of British Columbia, Vancouver Coastal Health Research Institute, Healthy Minds Canada, Pfizer
Depression
11/22
12/22
ENABLE, NCT06408012: An Innovative Master Platform for Clinical Trials in Mood Disorders

Recruiting
N/A
900
Canada
St. Joseph's Healthcare Hamilton, Unity Health Toronto, Centre for Addiction and Mental Health, Queen's University, University of Ottawa, University of British Columbia, University of Calgary, McGill University, Nova Scotia Health Authority, University of Michigan, Simon Fraser University, University Health Network, Toronto
Mood Disorders, Depressive Disorder, Bipolar and Related Disorders
03/26
03/26
Y-PRIME, NCT06753344: Youth Promotion of Resilience Involving Mental E-health

Not yet recruiting
N/A
1800
RoW
Intervention app
University of British Columbia, St. Francis Xavier University, Institute of Population, Health and Development, Vietnam, Simon Fraser University, University of Melbourne
Mental Well-being, Resilience, Population Study
03/28
03/28
NCT05423275: Light and Ion Maintenance In Treatment for Depression (LIMIT-D): Feasibility Study

Recruiting
N/A
100
Canada
Negative ion therapy, Light therapy
University of British Columbia, University of Toronto, Université de Montréal, Canadian Institutes of Health Research (CIHR), McMaster University, Ontario Brain Institute, Centre for Addiction and Mental Health
Major Depressive Disorder, Recurrent, in Remission
12/26
06/27
Vila-Rodriguez, Fidel
PORT, NCT05028738: Patient-oriented Randomized Pragmatic Feasibility Trial with RTMS in Depression and Anxiety

Recruiting
N/A
100
Canada
Repetitive Transcranial Magnetic Stimulation
University of British Columbia
Major Depressive Episode, Major Depressive Disorder
07/25
08/25
MST-PD, NCT04784494: MST for Parkinson's Disease

Active, not recruiting
N/A
20
Canada
Magnetic Seizure Theapy (MagPro XP MST), MagPro MST (Tonica Elektronik A/S, Denmark)
University of British Columbia
Parkinson Disease, Depression, Movement Disorders, Major Depressive Disorder
07/24
02/25
NCT04255784: High Dose Accelerated ITBS for Depression

Completed
N/A
228
Canada
Active iTBS, Sham iTBS
Centre for Addiction and Mental Health, University Health Network, Toronto, University of British Columbia
Major Depressive Disorder
01/25
01/25
CORRECT-C, NCT03711019: Efficacy of Convulsive Therapies During Continuation

Completed
N/A
106
Canada
Magnetic Seizure Therapy (MST), MST, RUL-UB ECT, Bitemporal ECT, ECT
Centre for Addiction and Mental Health, University of British Columbia, Ontario Shores Centre for Mental Health Sciences, Brain Canada
Depression, Bipolar Depression, Unipolar Depression, Treatment Resistant Depression
10/24
10/24
CORRECT-BD, NCT03641300: Efficacy of Convulsive Therapies for Bipolar Depression

Completed
N/A
76
Canada
Magnetic Seizure Therapy (MST), MST, Electroconvulsive Therapy (ECT), ECT
Centre for Addiction and Mental Health, University of British Columbia, Ontario Shores Centre for Mental Health Sciences, Brain Canada
Bipolar Disorder, Bipolar Depression, Bipolar I Disorder, Bipolar II Disorder
03/24
08/24
MAST, NCT06672588: Magnetic Seizure Therapy for Schizophrenia - Trial

Not yet recruiting
N/A
80
Canada
Magnetic Seizure Therapy (MST), MST, Electroconvulsive Therapy (ECT), ECT
Centre for Addiction and Mental Health, University of British Columbia
Treatment Resistant Schizophrenia, Schizophrenia, Schizoaffective Disorder
11/28
11/28
NCP, NCT05139862: Neurocardiac Predictors of Treatment Response to RTMS in Depression

Not yet recruiting
N/A
110
Canada
Repetitive Transcranial Magnetic Stimulation, rTMS
University of British Columbia, Canadian Institutes of Health Research (CIHR)
Depression, Treatment Resistant Depression
12/28
12/28
NCT06746857: ITBS-Neurosplasticity for Female Youth with Depression

Not yet recruiting
N/A
8
NA
repetitive transcranial magnetic stimulation
University of British Columbia
Depressive Disorder
08/27
08/27
LeRNIT, NCT04999553: Left vs. Right Non-Inferiority Trial

Recruiting
N/A
420
Canada
Repetitive Transcranial Magnetic Stimulation, Intermittent Theta Burst Stimulation (iTBS), Low Frequency Right (LFR)
University of British Columbia, Centre for Addiction and Mental Health
Depression, Major Depressive Disorder, Major Depressive Episode
02/26
02/26
Reid, Shannon
CBD-BD, NCT05867849: Cannabidiol for Bipolar Depression

Recruiting
3
360
Canada
Cannabidiol, CBD, Placebo
University of British Columbia
Bipolar Disorder
12/29
12/30
Chakrabarty, Trisha
NCT04944758: Feasibility of Adherence to Light Therapy

Terminated
N/A
1
Canada
Light therapy
University of British Columbia, Michael Smith Foundation for Health Research
Major Depression in Remission
06/22
06/22
NCT06546917: bWell-D Pilot Randomized Controlled Trial

Not yet recruiting
N/A
70
NA
bWell Cognitive Remediation, VR Experience
University of British Columbia, Simon Fraser University, National Research Council, Canada
Depressive Disorder, Major, Cognitive Dysfunction
08/26
08/26
Keramatian, Kam
NCT04944758: Feasibility of Adherence to Light Therapy

Terminated
N/A
1
Canada
Light therapy
University of British Columbia, Michael Smith Foundation for Health Research
Major Depression in Remission
06/22
06/22
Robertson, Heather
MIDI, NCT04368481: (MR Imaging Abnormality Deep Learning Identification)

Recruiting
N/A
30000
Europe
King's College Hospital NHS Trust, King's College London
Neurological Disorder
08/24
03/25
Evans, Vanessa
CAN-BIND-17, NCT05017311: Optimized Predictive Treatment In Medications for Unipolar Major Depression (OPTIMUM-D)

Recruiting
4
400
Canada
Escitalopram, Cipralex, Brexpiprazole, Rexulti
Nova Scotia Health Authority, Unity Health Toronto, Centre for Addiction and Mental Health, McMaster University, Queen's University, University of Ottawa, University of British Columbia, University of Calgary, McGill University, Dalhousie University, University of Michigan, Simon Fraser University
Major Depressive Disorder
12/28
04/29
NCT04162522: Canadian Biomarker Integration Network for Depression (CAN-BIND) - Validation Study

Completed
3
1
Canada
Escitalopram, Cipralex, Brexpiprazole, Rexulti
University Health Network, Toronto, Unity Health Toronto, Baycrest, Centre for Addiction and Mental Health, McMaster University, Queen's University, University of Ottawa, University of British Columbia, University of Calgary, McGill University, Dalhousie University, University of Michigan, Simon Fraser University
Major Depressive Disorder
12/22
12/22
NCT04944758: Feasibility of Adherence to Light Therapy

Terminated
N/A
1
Canada
Light therapy
University of British Columbia, Michael Smith Foundation for Health Research
Major Depression in Remission
06/22
06/22
NCT05423275: Light and Ion Maintenance In Treatment for Depression (LIMIT-D): Feasibility Study

Recruiting
N/A
100
Canada
Negative ion therapy, Light therapy
University of British Columbia, University of Toronto, Université de Montréal, Canadian Institutes of Health Research (CIHR), McMaster University, Ontario Brain Institute, Centre for Addiction and Mental Health
Major Depressive Disorder, Recurrent, in Remission
12/26
06/27
Do, Andre
NCT04944758: Feasibility of Adherence to Light Therapy

Terminated
N/A
1
Canada
Light therapy
University of British Columbia, Michael Smith Foundation for Health Research
Major Depression in Remission
06/22
06/22

Download Options